BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

PerkinElmer, Inc. (PKI) to Add 100 Workers to New Personalized Health Center


6/7/2012 10:03:33 AM

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced that it will establish a new Personalized Health Innovation Center of Excellence. The Center will focus on accelerating scientific innovation to help researchers who are working to eradicate disease and extend the quality and longevity of life.

The mission of the Center will be to create new enabling technologies for scientists developing and commercializing new diagnostic and therapeutic products. Located at the Company’s facility in Hopkinton, Massachusetts, the Center will expand to a total of 350 employees and is projected to be fully operational by late 2012.

Kevin Hrusovsky, President, Life Sciences & Technology, PerkinElmer, said, “We are delighted to establish our new Center of Excellence, which will serve as an exciting example of PerkinElmer’s commitment to, and culture of, innovation. It will act as a foundation and catalyst for future advances in personalized health, as it concentrates the knowledge of our life sciences R&D and commercial leaders for greater scientific collaboration. The expertise promoted by the Center will help bring novel and disruptive solutions to our customers, aiding their research in next generation treatments, early detection and disease prevention.”

The newly developed Center will bring together leaders from within PerkinElmer's chemistry, biochemistry, cell biology, molecular biology and reagent development R&D teams. PerkinElmer will leverage its scientific expertise with the goal of developing transformative in vitro to in vivo solutions, facilitating the development of personalized health solutions in the clinic. The facility will focus on the collaborative development of key enabling applications solutions in genomics, imaging, biomarkers, biotherapeutics, targeted small molecule development and cell-based assay solutions. It will also showcase a complete solutions-based demonstration laboratory for customers and collaborators.

About PerkinElmer, Inc.

PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. The Company reported revenue of approximately $1.9 billion in 2011, has about 7,000 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.

Contacts

PerkinElmer, Inc.

Mario Fante, 781-663-5602

Corporate Public Relations Manager

mario.fante@perkinelmer.com

or

Edelman (On behalf of PerkinElmer, Inc.)

Amanda Lazaro Connolly, 404-832-6785

Amanda.Connolly@edelman.com




   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES